DC-based immunotherapy for relapsed high grade glioma: clinical update of cohort A, B, C and D from the cohort comparison trial HGG-immuno-2003

S. De Vleeschouwer, H. Ardon, S. Fieuws, F. Van Calenbergh, J. Goffin, J. Van Loon & S. Van Gool
Objective: The prognosis of patients with high-grade glioma (HGG) is dismal. We investigate the therapeutic role of vaccination with mature dendritic cells (DC) loaded with tumor lysates derived from resected tumor at the time of a relapse. Methods: Dendritis cells were injected intradermally according[for full text, please go to the a.m. URL]